Prostate-Associated Gene 4 (PAGE4) is a disordered protein implicated in the progression of prostate cancer. PAGE4 can be phosphorylated at two residue sites by Homeodomain-Interacting Protein Kinase 1 (HIPK1) to facilitate its binding to the Activator Protein-1 (AP-1) transcription factor. Contrarily, a further hyperphosphorylation of PAGE4 by CDC-Like Kinase 2 (CLK2) reduces its binding affinity to AP-1, thus affecting androgen receptor (AR) activity levels downstream. Both Small-angle X-ray scattering (SAXS) and Single molecule fluorescence resonance energy transfer (smFRET) experiments show an expansion of PAGE4 upon hyperphosphorylation and a more significant increase in size in its N-terminal half than that in its C terminus.To understand the underlying mechanism behind this structural transition, we performed a set 1 . 14, 2018; of constant temperature molecular dynamics simulations (MDS) with Atomistic AWSEM -a multi-scale model combining detailed atomistic and coarse-grained simulation approaches. By simulating PAGE4 in its wildtype and phosphorylated forms, our simulations reveal that electrostatic interaction drives a transient formation of a N-terminal loop, which causes the change of size in different forms of PAGE4. Phosphorylation also changes the preference of secondary structure formation in different forms of PAGE4, which signifies transition between states that have different degrees of disorder. Finally, we construct a mechanism-based mathematical model capturing the interactions of different forms of PAGE4 with the AP-1 and AR, a key therapeutic target in prostate cancer. Our model predicts intracellular oscillatory dynamics of HIPK1-PAGE4, CLK2-PAGE4 and AR activity, indicating phenotypic heterogeneity in an isogenic cell population. Thus, conformational switching among different forms of PAGE4 may potentially affect the efficiency of therapeutic targeting of AR.
CC-BY-NC-ND 4.0 International licenseIt is made available under a (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint . http://dx.doi.org/10.1101/264010 doi: bioRxiv preprint first posted online Feb.